DE1954839A1 - Tetrazole derivatives - Google Patents

Tetrazole derivatives

Info

Publication number
DE1954839A1
DE1954839A1 DE19691954839 DE1954839A DE1954839A1 DE 1954839 A1 DE1954839 A1 DE 1954839A1 DE 19691954839 DE19691954839 DE 19691954839 DE 1954839 A DE1954839 A DE 1954839A DE 1954839 A1 DE1954839 A1 DE 1954839A1
Authority
DE
Germany
Prior art keywords
tetrazole
general formula
carbon atoms
carboxy
benzoxazepin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691954839
Other languages
German (de)
Inventor
Selway Rupert Aleck
Howes John Gordon Bernard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew PLC
Original Assignee
Smith and Nephew PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith and Nephew PLC filed Critical Smith and Nephew PLC
Publication of DE1954839A1 publication Critical patent/DE1954839A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Dr. Ing. E. BERKENFELD · Dipl.-lng. H. BERKENFELD, Patentanwälte, KölnDr. Ing. E. BERKENFELD · Dipl.-Ing. H. BERKENFELD, patent attorneys, Cologne Anlage AktenzeichenAttachment file number

zurEingabevom JQ. Oktober 1909 Sch/ Name d. Anm. T.J. Smith & NepheW Ltd.for entering JQ. October 1909 Sch / Name d. Note TJ Smith & NepheW Ltd.

Tetrazolderivate.Tetrazole derivatives.

Die Erfindung betrifft Tetrazolderivate und ein Verfahren zu ihrer Herstellung.The invention relates to tetrazole derivatives and a method for their manufacture.

Die Erfindung betrifft Tetrazolderivate der allgemeinen Formel The invention relates to tetrazole derivatives of the general formula

in der R1 Wasserstoff, bis 6 Kohlenstoffatome aufweisendes Alkyl, bis 6 Kohlenstoffatome aufweisendes Alkoxy, Halogen oder Trifluormethyl bedeutet»in which R 1 is hydrogen, alkyl having up to 6 carbon atoms, alkoxy, halogen or trifluoromethyl having up to 6 carbon atoms »

Derivate der allgemeinen Formel I werden erfindungsgemäß in der Weise hergestellt, daß man eine Verbindung der allgemeinen FormelDerivatives of the general formula I are according to the invention in made in such a way that one can connect the general formula

3 34/30 -T-3 34/30 -T-

009819/1882009819/1882

i N-N i NN

II HII H

dehydratisiert, in der R1 die vorstehend angegebene Bedeutung hat.dehydrated, in which R 1 has the meaning given above.

Eine Dehydratation kann z.B. mittels Thionylchlorid durchgeführt werden.Dehydration can be carried out using thionyl chloride, for example will.

Die Verbindungen der allgemeinen Formel II sind neu und sind Gegenstand der Erfindung.The compounds of the general formula II are new and are the subject matter the invention.

Die Erfindung betrifft ferner ein Verfahren zum Herstellen der Verbindungen der allgemeinen Formel II, gemäß welchem man eine Verbindung der allgemeinen FormelThe invention also relates to a method for producing the Compounds of the general formula II, according to which a compound of the general formula

HI.HI.

hydrolysiert, in der R^ die vorstehend angegebene Bedeutung hat, und R1J und R, die Beudeutung wie Rt haben.hydrolyzed, in which R ^ has the meaning given above, and R 1 J and R, which have the meaning as R t .

Die Hydrolyse kann z.B. mittels einer 20#igen wässrigen Bfatriumhydroxydlösung durchgeführt werden.The hydrolysis can be carried out, for example, by means of a 20 # strength aqueous sodium hydroxide solution be performed.

3 54/30 -2-3 54/30 -2-

009819/1882009819/1882

-3*' 195A839-3 * '195A839

Die Verbindungen der allgemeinen Formel I können als Zwischenprodukte zur Herstellung der in der schwebenden Anmeldung S 34/25+ offenbarten substituierten Tetrazole verwendet werden, bei welchen es sich um Anaigetika und entzündungswidrige Mittel handelt.The compounds of general formula I can be used as intermediates for the production of the pending application S 34/25 + substituted tetrazoles disclosed which are anaigetics and anti-inflammatory agents can be used.

+ P 18 06 5^6.8+ P 18 06 5 ^ 6.8

Die Erfindung 1st in den folgenden Beispielen näher beschrieben.The invention is described in more detail in the following examples.

Beispiel IExample I. Tetrazol(5.1-c)2,3«4,5-tetrahydro-1,4-benzoxazepin-5-onTetrazole (5.1-c) 2,3 «4,5-tetrahydro-1,4-benzoxazepin-5-one

• Es wurden 44 g (0,20 Mol) 5-(2-Carboxyphenoxymethyl)-tetrazol mit 82 g (0,69 Mol) Thionylchlorid, das 2 Tropfen N,N-Dimethylformamld enthielt, in der Kälte behandelt. Nach einer Stunde wurde das Reaktionsgemisch langsam bis zur RUcklauftemperatur erwärmt und bei dieser Temperatur zwei Stunden gehalten, überschüssiges Thionylchlorid wurde entfernt und 31,2 g (785ε) eines braunen festen Stoffes erhalten, dessen Schmelzpunkt unter Zersetzung sich auf 128 - 133OC belief. Eine Kristallisation aus Benzol ergab das gewünschte Produkt mit einem Schmelzpunkt .von 135 - 1360C unter Zersetzung.• 44 g (0.20 mol) of 5- (2-carboxyphenoxymethyl) tetrazole were treated in the cold with 82 g (0.69 mol) of thionyl chloride containing 2 drops of N, N-dimethylformamide. After one hour, the reaction mixture was slowly heated to the return flow temperature and held for two hours at this temperature, excess thionyl chloride was obtained away and 31.2 g (785ε) of a brown solid substance having a melting point with decomposition at 128 - was 133 O C. Crystallization from benzene yielded the desired product having a melting point .of 135-136 0 C with decomposition.

C9H6N4O2 C 9 H 6 N 4 O 2

CC. 16;16; 22 HH NN gefunden:found: 53,53 4646 22 ,94, 94 27,27, erfordertrequires 53,53 ,99, 99 27,27,

Die folgenden Verbindungen wurden aus in zweckmäßiger Weise substituierten Zwischenprodukten nach einer dem Beispiel I entsprechenden Methode hergestellt.The following compounds have been appropriately substituted from Intermediate products prepared by a method corresponding to Example I.

Beispiel II 7-Chlor-tetrazol(5j1-c)*-2,3,4,5-tetrahydro-1,4-benzoxazepln- Example II 7-chloro-tetrazole (5j1-c) * - 2,3,4,5-tetrahydro-1,4-benzoxazepln -

Weifle Nadeln aus Aceton, F = I9I - 192°CWhite needles made of acetone, F = 19I - 192 ° C

H NH N

gefunden : 45,91 2,35 23,1found: 45.91 2.35 23.1

erfordert: 45,68 2,13 23,68#Requires: 45.68 2.13 23.68 #

009819/1882 ~3'009819/1882 ~ 3 '

Beispiel IIIExample III

7-Methyl-tetrazol-(5j1-c)-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-methyl-tetrazole- (5j1-c) -2,3,4,5-tetrahydro-1,4-benzoxazepine-

5-on5-on

Farblose Stäbchen aus Aceton; P= 174 - 175°C.Colorless sticks made from acetone; P = 174-175 ° C.

C H NC H N

2 gefunden ϊ 55,82 3,85 25,74# erfordert: 55,55 3,73 25,92# 2 found ϊ 55.82 3.85 25.74 # requires: 55.55 3.73 25.92 #

Beispiel IVExample IV

8-Methoxy-tetrazol-(5J1-c)-2,3,4f5-tetrahydro-1,4-benzoxazepin-8-methoxy-tetrazole- (5 J 1-c) -2,3,4 f 5-tetrahydro-1,4-benzoxazepine-

Schwach gelblich gefärbte Nadeln aus Benzol; F= 186 - 187Pale yellow needles made from benzene; F = 186-187

C H NC H N

gefunden :found : 5151 ,77, 77 3,3, 5353 24,24, erfordert:requires: 5151 ,72, 72 3,3, 4747 24,24,

Die Herstellung der Zwischenprodukte, die noch nicht in der Literatur beschrieben wurden, ist nachstehend angegeben.The manufacture of intermediates, which is not yet in the literature is given below.

Präparat 1 5-(2-Carboxyphenoxymethyl)-tetrazolPreparation 1 5- (2-carboxyphenoxymethyl) tetrazole

Es wurden 8,55 g (0,029 Mol) 5-(2-Phenylcarbamoyl)-phenoxymethyl)· tetrazol in 75 ml einer 20#igen Natriumhydroxydlösung gelöst und fünf Stunden unter Rücklauf gekocht. Die gekühlte Lösung wurde mit 2 χ 50 ml Äthylacetat extrahiert und dann sorgfältig mit konzentrierter Salzsäure auf ein pH von 2 angesäuert, um einen weißen festen Stoff zu fällen. Der Feststoff wurde abfiltriert, mit Wasser gewaschen und getrocknet und 5,76 g (90$) eines Produktes mit einem Schmelzpunkt von 201 - 2020C erhalten. Eine Kristallisation aus Aceton:Wassergemisch (1:1 v/v) ergab einen8.55 g (0.029 mol) of 5- (2-phenylcarbamoyl) phenoxymethyl) tetrazole were dissolved in 75 ml of a 20% sodium hydroxide solution and refluxed for five hours. The cooled solution was extracted with 2 × 50 ml of ethyl acetate and then carefully acidified to pH 2 with concentrated hydrochloric acid to precipitate a white solid. The solid was filtered off, washed with water and dried, and 5.76 g (90 $) of a product having a melting point of 201 - 202 obtained 0C. Crystallization from acetone: water mixture (1: 1 v / v) gave a

S 34/30 -4-S 34/30 -4-

009819/1882009819/1882

weißen kristallinen festen Stoff mit einem Schmelzpunkt von 204 - 205°C.white crystalline solid with a melting point of 204 - 205 ° C.

CHNCHN

gefunden: 48,94 3,39 25,225gfound: 48.94 3.39 25.225g

erfordert: 49,09 3,66 25,requires: 49.09 3.66 25,

Präparat 2Preparation 2

5-(2-Carboxy-4-chlorphenoxymethyl)-tetrazol5- (2-carboxy-4-chlorophenoxymethyl) tetrazole

Hergestellt aus 5- ^~2-(Phenylcarbamoyl)-4-chlorphenoxymethyl_7Made from 5- ^ ~ 2- (phenylcarbamoyl) -4-chlorophenoxymethyl_7

tetrazol Weiße Nadeln nus Aceton; P = 210 - 2110C.tetrazole White needles with acetone; P = 210-211 0 C.

CHNCHN

C9H7ClN4O3 gefunden : 42,18 2,95 22,31$C 9 H 7 ClN 4 O 3 found: 42.18 $ 2.95 22.31

erfordert : 42,45 2,77 22,01$Requires: 42.45 $ 2.77 $ 22.01

Präparat 3Preparation 3

5-(2-Carboxy-4-methylphenoxymethyl)-tetrazol5- (2-carboxy-4-methylphenoxymethyl) tetrazole

Hergestellt aus 5- ^~2-(Phenylcarbamoyl)-4-methylphenoxymethyl7Made from 5- ^ ~ 2- (phenylcarbamoyl) -4-methylphenoxymethyl7

tetrazoltetrazole

Weiße Mikronadeln aus N,N-DimethyIformamid : Wasser (1:2 v/v); P = 188 - 1890CWhite microneedles made from N, N-dimethylformamide: water (1: 2 v / v); P = 188-189 0 C.

CHNCHN

gefunden : 51,37 4,15 24, erfordert: 51,28 4,30 23,92$found: 51.37 4.15 24, requires: 51.28 4.30 $ 23.92

3 34/30 -5-3 34/30 -5-

009819/1882009819/1882

->- ' 1954Ö39-> - '1954Ö39

Präparat 4Preparation 4

5-(2-Carboxy-5-methoxyphenoxymethyl)-tetrazol5- (2-carboxy-5-methoxyphenoxymethyl) tetrazole

Hergestellt aus 5-/~2-(3,4-Dichlorphenylcarbanioyl)-5-methoxyphenoxymethyl_7g tetrazol.Made from 5- / ~ 2- (3,4-dichlorophenylcarbanioyl) -5-methoxyphenoxymethyl_7g tetrazole.

Weißer kristalliner Stoff aus N,N-Din&hylformamid : Wasser (1:2 v/v); P = 220 - 221°C.White crystalline substance made from N, N-Din & hylformamide: water (1: 2 v / v); P = 220-221 ° C.

CHNCHN

gefunden: 48,06 4,0b 22,15#found: 48.06 4.0b 22.15 #

erfordert: 4ö,00 4,02requires: 4ö, 00 4.02

PatentansprücheClaims

009819/1882009819/1882

Claims (1)

Dr. Ing. E. BERKENFELD · Dipl.-lng. H. BERKENFELD, Patentanwälte, KölnDr. Ing. E. BERKENFELD · Dipl.-Ing. H. BERKENFELD, patent attorneys, Cologne Anlag« AktenzeichenAnnex «file number zur Eingab« vom 30. Oktober 1909 Seh/ Na«, d. Anm. τ. J. Smith & Nephew Ltd.to the input "from October 30, 1909 Seh / Na", d. Note τ. J. Smith & Nephew Ltd. Patentansprüche Tetrazolderivat der allgemeinen Formel: Claims tetrazole derivative of the general formula: in der R1 Wasserstoff, bis 6 Kohlenstoffatome enthaltendes Alkyl, bis 6 Kohlenstoffatome enthaltendes Alkoxy, Halogen oder Trifluormethyl bedeutet.in which R 1 is hydrogen, alkyl containing up to 6 carbon atoms, alkoxy containing up to 6 carbon atoms, halogen or trifluoromethyl. 2. Verfahren zum Herstellen von Verbindungen der allgemeinen Formel I gemäß Anspruch 1, dadurch gekennzeichnet, daß man eine Verbindung der allgemeinen Formel:2. Process for the preparation of compounds of the general formula I according to claim 1, characterized in that that one has a compound of the general formula: N-N
1
NN
1
COOHCOOH in der R1 die im Anspruch 1 angegebene Bedeutung hat, dehy* dratisiert.in which R 1 has the meaning given in claim 1, dehydrated. 3 24/30 -73 24/30 -7 009819/1882009819/1882 -»- 1354839- »- 1354839 j5. Verfahren nach Anspruch 2, dadurch gekennzeichnet, daß man die Dehydratation mittels Thionylchlorid durchführt.j5. Method according to claim 2, characterized in that the dehydration is carried out using thionyl chloride. eine Verbindung der allgemeinen Formel:a compound of the general formula: 0-CH2-C0-CH 2 -C COOHCOOH N-NN-N Il IlIl Il in der R1 die im Anspruch 1 angegebene Bedeutung hat.in which R 1 has the meaning given in claim 1. 5. Verfahren zum Herstellen von Verbindungen der allgemeinen Formel II gemäß Anspruch 2, dadurch gekennzeichnet, daß man eine Verbindung der allgemeinen Formel:5. Process for the preparation of compounds of the general formula II according to claim 2, characterized in that one compound of the general formula: III.III. in der R1 die im Anspruch 1 angegebene Bedeutung hat und R2 wie auch R-z Wasserstoff, bis 6 Kohlenstoff atome aufweisendes Alkyl, bis 6 Kohlenstoffatome aufweisendes Alkoxy, Halogen oder TrI-fluormethyl bedeuten, hydrolisiert.in which R 1 has the meaning given in claim 1 and R 2 and Rz are hydrogen, alkyl having up to 6 carbon atoms, alkoxy having up to 6 carbon atoms, halogen or tri-fluoromethyl, hydrolyzed. 0 09819/18 820 09819/18 82 6. Verfahren nach Anspruch 5* dadurch gekennzeichnet, daß man die Hydrolyse mittels einer 20#igen wässrigen Natriumhydroxyd· lösung durchführt.6. The method according to claim 5 *, characterized in that the hydrolysis is carried out using a 20 # aqueous sodium hydroxide solution carries out. 7. 7-Chlor-tetrazot(5»1-c)-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-on. 7. 7-chloro-tetrazot (5 »1-c) -2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one. 8. 7-Methyl-tetrazol-(5,1-c)-2,;3,4,5--tetrahydro-1,4-benzoxazepin-5-on. 8. 7-Methyl-tetrazol- (5,1-c) -2,; 3,4,5-tetrahydro-1,4-benzoxazepin-5-one. 9. 8-Methoxy-tetrazol-(5,1-c)-2,3,4,5-tet?rahydro-1,4-benzoxazepin-5-on. 9. 8-Methoxy-tetrazol- (5,1-c) -2,3,4,5-tet? Rahydro-1,4-benzoxazepin-5-one. 10. 5-(2-Carboxyphenoxymethyl)-tetrazol.10. 5- (2-Carboxyphenoxymethyl) tetrazole. 11. 5-(2-Carboxy-4-chlorphenoxymethyl)-tetrazol.11. 5- (2-Carboxy-4-chlorophenoxymethyl) tetrazole. 12. 5- ^-Carboxy^-methylphenoxymethyl) -tetrazol. 13 · 5- (2-Carboxy-5-iTiethoxyphenoxymethyl) -tetrazol.12. 5- ^ -Carboxy ^ -methylphenoxymethyl) tetrazole. 13 • 5- (2-Carboxy-5-Itiethoxyphenoxymethyl) -tetrazole. 009819/1882009819/1882
DE19691954839 1968-11-01 1969-10-31 Tetrazole derivatives Pending DE1954839A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5178168 1968-11-01

Publications (1)

Publication Number Publication Date
DE1954839A1 true DE1954839A1 (en) 1970-05-06

Family

ID=10461361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691954839 Pending DE1954839A1 (en) 1968-11-01 1969-10-31 Tetrazole derivatives

Country Status (4)

Country Link
DE (1) DE1954839A1 (en)
FR (1) FR2022378A1 (en)
GB (1) GB1238719A (en)
SE (1) SE363636B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102808A2 (en) * 2001-06-14 2002-12-27 Akzo Nobel N.V. (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR
US7307073B2 (en) 2001-06-11 2007-12-11 N.V. Organon Benzoxazepines derivatives and their use as AMPA receptor stimulators

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7307073B2 (en) 2001-06-11 2007-12-11 N.V. Organon Benzoxazepines derivatives and their use as AMPA receptor stimulators
US7504390B2 (en) 2001-06-11 2009-03-17 N.V. Organon Benzoxazepine derivatives and their use as AMPA receptor stimulators
WO2002102808A2 (en) * 2001-06-14 2002-12-27 Akzo Nobel N.V. (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR
WO2002102808A3 (en) * 2001-06-14 2003-03-20 Akzo Nobel Nv (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR
US7345036B2 (en) 2001-06-14 2008-03-18 N.V. Organon (Pyrido/thieno)—[f]—oxazepine-5-one derivatives
US7566778B2 (en) 2001-06-14 2009-07-28 N.V. Organon (Pyrido/thieno)-[f]-oxazepine-5-one derivatives
US8034804B2 (en) 2001-06-14 2011-10-11 N.V. Organon (Pyrido/thieno)-[f]-oxazepine-5-one derivatives

Also Published As

Publication number Publication date
GB1238719A (en) 1971-07-07
FR2022378A1 (en) 1970-07-31
SE363636B (en) 1974-01-28

Similar Documents

Publication Publication Date Title
DE2359536C2 (en) 2,6-diaminonebularin derivatives
DE2346034A1 (en) ALPHA-METHYL-2-PHENYL-5-BENZOTHIAZOLYL ACID ACID
DE1954839A1 (en) Tetrazole derivatives
DE1806546A1 (en) Tetrazoles
DE1745780B2 (en) 1-SULFONYLAETHYL-2-METHYL-5-NITROIMIDAZOLE AND THE METHOD OF MANUFACTURING IT
DE2033090C3 (en) their manufacture
AT323154B (en) PROCESS FOR THE PRODUCTION OF NEW 5-METHOXY-2-METHYLINDOL-3-ACETIC ACID DERIVATIVES AND OF THEIR SALTS
DE1695914C3 (en) Process for the preparation of 1 di alkylaminoethyl 2 methyl 3 aryl 4 oxo 1,2,3,4 tetrahydroquinazolines
DE1745780C3 (en) l-Sulfonyläthyl ^ -methyl-S-nitroimidazole and process for their preparation
DE2022746A1 (en) Blood sugar lowering sulfonylaminopyrimidines and processes for their preparation
AT354432B (en) METHOD FOR PRODUCING 3-INDOLYLESSIC ACIDS
DE2404924A1 (en) ERGOLINE DERIVATIVES
AT296316B (en) Process for the preparation of new benzodiazepine derivatives and their N-4-oxides
DE737931C (en) Process for the preparation of 2,4-diaminochinazoline
DE2218248C3 (en) Picolinic acid dithiocarbamates
DE1493619C (en) Process for the preparation of 3- (3,4-dihydroxyphenyl) -2-methylalanine
DE1620054C (en) Process for the preparation of quinolindenvates and drugs containing these compounds excretion from 1470047
DE2131158A1 (en) Benzodiazepine derivatives
AT211823B (en) Process for the preparation of new aryloxyacetic acid amides
DE1545901C (en) Process for the preparation of 2-mercaptoimidazole derivatives and their salts
DE1620395A1 (en) Process for the preparation of cycloheptimidazolinium halides
DE1135478B (en) Process for the preparation of 3, 5-dioxo-1, 2, 4-triazolidines
DE1111200B (en) Process for the preparation of 1, 2, 4-Benzothiadiazin-1, 1-dioxyden
DE2429561A1 (en) PROCESS FOR THE PRODUCTION OF SUBSTITUTED AMINOPHENOLS
CH535783A (en) Pyrimidine ester derivs - hypnotics and sedatives esp 2,4-bis morpholino-and thiamorpholino-5-carboxy pyrimidine esters